Method of treatment for lymphedema comprising administering a polynucleotide encoding VEGF-D
US8357669B2 · kind B2 · utility
0Cited by
37References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 23, 2011 |
| Grant date | Jan 22, 2013 |
| Priority date | — |
| Expiry date | Sep 23, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides materials and methods for screening for and treating hereditary lymphedema in human subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.